Effects of Chemotherapy Clinical Trial
Official title:
The Effects of Cancer Treatment on Ovarian Function: A Longitudinal Study by the Oncofertility Consortium
Postmenarchal female cancer patients scheduled to undergo cancer therapy may enroll in this study to assess changes in existing and novel surrogate measures of fertility potential before, during and after chemotherapy. Measures of fertility potential to be tested include ultrasound imaging for antral follicle counts and ovarian volumes, endocrine evaluation, and assessment of oxidative stress.
Eligible women are asked to complete a structured interview, questionnaires, a monthly
menstrual diary, a brief physical examination, a blood test, and an abdominal or pelvic
ultrasound at baseline and at 3 month intervals following start of chemotherapy through 6
months post end of treatment.
Within subject changes in continuous variables (hormones, urinary isoprostane levels,
ovarian volume, AFC) will be compared using paired t-tests (nonparametric tests as
appropriate). Non-Gaussian-distributed variables will be logarithmically transformed prior
to analysis. In general, changes from baseline to every 3 month assessment will be compared
individually as well as changes from baseline to post treatment. In addition, regression
models for repeated measures will be used to describe the pattern of change in these
outcomes over time. Additional models will be constructed to adjust for potential
confounding variables including age, chemotherapy type, dose and duration of treatment,
radiation treatment, gonadotropin releasing hormone agonist use, and hormone use. Finally,
regression models will be used to evaluate the association between changes in urinary
isoprostane levels over the study with changes in endocrine measures.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05529940 -
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
|
Phase 3 | |
Recruiting |
NCT02306837 -
Consolidation Chemotherapy After Autologous Stem Cell Transplantation for Lymphoid Malignancies
|
Phase 2 | |
Completed |
NCT02771470 -
Intestinal Microflora in Lung Cancer After Chemotherapy
|
Phase 1 | |
Completed |
NCT02454673 -
Therapeutic Individualization for Patients With Locally Advanced Gastric and Gastroesophageal Cancer
|
N/A | |
Completed |
NCT02454647 -
Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients
|
N/A | |
Completed |
NCT01432223 -
Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab
|
Phase 2 | |
Completed |
NCT02767388 -
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
|
||
Recruiting |
NCT02555592 -
Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level
|
N/A | |
Suspended |
NCT02121405 -
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
|
Phase 3 | |
Recruiting |
NCT02226380 -
FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer
|
Phase 2 | |
Completed |
NCT03840824 -
Blood Spot Self-administered Test and Assay
|
||
Completed |
NCT00911352 -
Cryotherapy Intervention for Docetaxel-induced Nail Toxicities
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT01490060 -
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
|
N/A | |
Recruiting |
NCT05268991 -
Aging and Frailty Study
|
||
Recruiting |
NCT03885388 -
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6
|
Phase 2/Phase 3 | |
Completed |
NCT02375776 -
Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention
|
N/A | |
Enrolling by invitation |
NCT02074241 -
Molecular Markers of Chemosensitivity for Bladder Cancer
|
N/A | |
Completed |
NCT01143844 -
Assessing Fertility Potential in Female Cancer Survivors
|
||
Recruiting |
NCT02169388 -
Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy
|
Phase 1 | |
Completed |
NCT03402295 -
Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
|
Phase 3 |